Skip to main content
38°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Novartis' Breast Cancer PI3K Drug, Scores FDA Approval For Ultra-Rare Indication
April 06, 2022
Tickers
NVS
Tags
FDA
General
NVS
From
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Tickers
BGNE
BTAI
CCCC
CTXR
Tags
General
Small Cap
LBPH
From
Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
Tags
General
Market News
NVS
From
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Tickers
ACAD
ARGX
ATRA
BMY
Tags
IBB
ARGX
FDA
From
Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
Tickers
ABBV
ALNY
AMGN
APTX
Tags
BMY
HCM
Market News
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
April 04, 2022
Tickers
AAPL
CRRFY
FRCOY
MMM
Tags
$BTC
AAPL
XOM
From
Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
April 04, 2022
Tickers
NVS
Tags
News
Large Cap
Health Care
From
Benzinga
3 CEOs to Invest In
April 01, 2022
Tickers
ANTM
AXSM
AZN
GH
Tags
ANTM
Market News
NVS
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
BTAI
Small Cap
General
From
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
Tickers
ACMR
AMGN
BABA
BGNE
Tags
BGNE
HCM
Market News
From
InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
KALA
AFIB
ITRM
From
Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
March 27, 2022
Tickers
AZN
GRFS
GSK
JNJ
Tags
NVAX
PFE
GRFS
From
Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
March 25, 2022
Tickers
NVS
Tags
Health Care
Benzinga
Biotech
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers
AMGN
CANF
NVS
Tags
Partner Content
General
Biotech
From
Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
March 24, 2022
Tickers
NVS
Tags
Briefs
Large Cap
News
From
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
TFFP
IMMP
DGX
From
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
March 22, 2022
Tickers
FUSN
LNTH
NVS
PNT
Tags
NVS
Market News
YMAB
From
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Tickers
ADMP
AGTC
ANAB
APTO
Tags
ANAB
ORIC
MRK
From
Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
March 22, 2022
Tickers
BABA
BYDDY
CP
FB
Tags
News
Cryptocurrency
TSLA
From
Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
March 22, 2022
Tickers
NVS
Tags
General
Ukraine/Russia War
NVS
From
Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
CORT
JP:NIK
BMY
From
MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
March 19, 2022
Tickers
NVS
PFE
VYGR
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
RHHBY
NVS
Recent Press Releases
From
Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
March 14, 2022
Tickers
NVS
Tags
Trading Ideas
Health Care
News
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
BIIB
General
RHHBY
From
Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
March 14, 2022
Tickers
CING
JNJ
NVS
Tags
Partner Content
Market News
NVS
From
Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
March 14, 2022
Tickers
CRSP
LLY
NVS
VRTX
Tags
LLY
CRSP
VRTX
From
Motley Fool
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
March 11, 2022
Tickers
HCM
JNJ
NVS
Tags
Benzinga
JNJ
NVS
From
Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
March 10, 2022
Tickers
NVS
Tags
breast cancer
NVS
Market News
From
Benzinga
< Previous
1
2
...
18
19
20
21
22
23
24
25
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.